Filing Details
- Accession Number:
- 0001104659-13-068468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-06 16:09:29
- Reporting Period:
- 2013-09-04
- Filing Date:
- 2013-09-06
- Accepted Time:
- 2013-09-06 16:09:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236367 | J Michael Astrue | C/O Vivus, Inc. 351 East Evelyn Avenue Mountain View CA 94041 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-09-04 | 10,000 | $11.96 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $11.9550 to $11.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.